<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39333387</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0447</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>27</Day></PubDate></JournalIssue><Title>Pediatric research</Title><ISOAbbreviation>Pediatr Res</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 condition in children: epidemiological evidence stratified by acute disease severity.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41390-024-03597-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To determine the prevalence of pediatric Post-COVID-19 condition (PPCC), identify risk factors, and assess the quality of life in children with differing severities of acute COVID-19.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">During a prospective longitudinal study with a 1-year follow-up, we compared non-hospitalized (mild) and hospitalized (severe) COVID-19 cases to a negatively tested control group.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">579 children were included in this study. Of these, 260 had mild acute disease (median age:8, IQR:6-10), 60 had severe acute disease (median age:1, IQR:0.1-4.0), and 259 tested negative for SARS-CoV-2 (NT) (median age:8, IQR:5-10). At three months, 14.6% of the SARS-CoV-2 positive mild group (RR:6.31 (CI 95%: 2.71-14.67)) and 29.2% of the severe group (RR:12.95 (CI 95%: 5.37-31.23)) reported sequelae, versus 2.3% of the NT group. PPCC prevalence in the mild group decreased from 16.1% at one month to 4.4% at one year. Children with PPCC exhibited lower physical health-related quality of life scores and higher fatigue scores than the NT children.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Severe acute COVID-19 in children leads to a higher PPCC prevalence than in mild cases. PPCC prevalence decreases over time. Risk factors at three months include prior medical history, hospital admission, and persistent fatigue one month after a positive test.</AbstractText><AbstractText Label="IMPACT" NlmCategory="CONCLUSIONS">We demonstrate children with severe COVID-19 are more likely to develop Post-COVID-19 condition than those with mild or no infections, and highlights the risk factors. Here we have stratified by acute disease severity, prospectively included a negative control group, and have demonstrated the heterogeneity in prevalence when utilizing various recent definitions of post-COVID. Identifying risk factors for pediatric post-COVID and highlighting the heterogeneity in prevalence based on various current definitions for post-COVID should aid in correctly identifying potential pediatric post-COVID cases, aiding in early intervention.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Lap</LastName><ForeName>Coen R</ForeName><Initials>CR</Initials><AffiliationInfo><Affiliation>Department of Pediatrics - Van Houten research group, Spaarne Gasthuis, Hoofddorp and Haarlem, Haarlem, The Netherlands. c.r.lap@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands. c.r.lap@amsterdamumc.nl.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital and University Medical Centre Utrecht, Utrecht, The Netherlands. c.r.lap@amsterdamumc.nl.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Brackel</LastName><ForeName>Caroline L H</ForeName><Initials>CLH</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Tergooi Medical Centrum, Hilversum, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winkel</LastName><ForeName>Angelique M A M</ForeName><Initials>AMAM</Initials><AffiliationInfo><Affiliation>Department of Pediatrics - Van Houten research group, Spaarne Gasthuis, Hoofddorp and Haarlem, Haarlem, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hashimoto</LastName><ForeName>Simone</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haverkort</LastName><ForeName>Milly</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infection Prevention and Control, Public Health Service (GGD) Kennemerland, Haarlem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noij</LastName><ForeName>Lieke C E</ForeName><Initials>LCE</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsem</LastName><ForeName>Mattijs W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Department of Rehabilitation Medicine, Amsterdam Movement Sciences, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Asmuth</LastName><ForeName>Erik G J</ForeName><Initials>EGJ</Initials><AffiliationInfo><Affiliation>Willem Alexander Children's Hospital, Leiden University Medical Centre, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bannier</LastName><ForeName>Michiel A G E</ForeName><Initials>MAGE</Initials><AffiliationInfo><Affiliation>Division of Pediatric Respiratory Medicine, Department of Pediatrics, MosaKids Children's Hospital, Maastricht University Medical Centre, Maastricht, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buddingh</LastName><ForeName>Emmeline P</ForeName><Initials>EP</Initials><AffiliationInfo><Affiliation>Willem Alexander Children's Hospital, Leiden University Medical Centre, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Goudoever</LastName><ForeName>Johannes B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haverman</LastName><ForeName>Lotte</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Child and Adolescent Psychiatry &amp; Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, Mental Health and Digital Health, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Reproduction and Development, Child Development, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Zee</LastName><ForeName>Anke H Maitland-</ForeName><Initials>AHM</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pulmonary Medicine, Amsterdam UMC University of Amsterdam, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mooij</LastName><ForeName>Miriam G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Pediatric Nephrology, Sophia Children's Hospital, Erasmus MC, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oostrom</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Child and Adolescent Psychiatry &amp; Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pijnenburg</LastName><ForeName>Mariëlle W</ForeName><Initials>MW</Initials><AffiliationInfo><Affiliation>Division of Pediatric Respiratory Medicine and Allergology, Department of Pediatrics, Erasmus MC -Sophia Children's Hospital, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kloosterman</LastName><ForeName>Sanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Pediatric Respiratory Medicine and Allergology, Department of Pediatrics, Erasmus MC -Sophia Children's Hospital, Rotterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teela</LastName><ForeName>Lorynn</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Child and Adolescent Psychiatry &amp; Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, Mental Health and Digital Health, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Reproduction and Development, Child Development, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luijten</LastName><ForeName>Michiel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Child and Adolescent Psychiatry &amp; Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Public Health, Mental Health and Digital Health, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Reproduction and Development, Child Development, Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tulling</LastName><ForeName>Adam J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Willem Alexander Children's Hospital, Leiden University Medical Centre, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lugthart</LastName><ForeName>Gertjan</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Willem Alexander Children's Hospital, Leiden University Medical Centre, Leiden, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogaert</LastName><ForeName>Debby</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatric Immunology and Infectious Diseases, Wilhelmina Children's Hospital and University Medical Centre Utrecht, Utrecht, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Biesbroek</LastName><ForeName>Giske</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatric Immunology, Rheumatology and Infectious Disease, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Houten</LastName><ForeName>Marlies A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics - Van Houten research group, Spaarne Gasthuis, Hoofddorp and Haarlem, Haarlem, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terheggen-Lagro</LastName><ForeName>Suzanne W J</ForeName><Initials>SWJ</Initials><AffiliationInfo><Affiliation>Department of Pediatric Pulmonology and Allergy, Emma Children's Hospital, Amsterdam University Medical Centre (Amsterdam UMC), University of Amsterdam (UvA), Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Res</MedlineTA><NlmUniqueID>0100714</NlmUniqueID><ISSNLinking>0031-3998</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>9</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>9</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>23</Hour><Minute>37</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39333387</ArticleId><ArticleId IdType="doi">10.1038/s41390-024-03597-3</ArticleId><ArticleId IdType="pii">10.1038/s41390-024-03597-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brodin, P. Immune responses to SARS-CoV-2 infection and vaccination in children. Semin Immunol. 69, 101794 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2023.101794</ArticleId><ArticleId IdType="pubmed">37536147</ArticleId></ArticleIdList></Reference><Reference><Citation>RIVM. Actuele informatie over het nieuwe coronavirus (COVID-19). Actuele informatie over het nieuwe coronavirus (COVID-19) | RIVM 1–1 https://www.rivm.nl/coronavirus-covid-19/actueel%0A . https://www.rivm.nl/nieuws/actuele-informatie-over-coronavirus (2020).</Citation></Reference><Reference><Citation>StatLine. Jongeren (0 tot 25 jaar); geslacht, leeftijd, migratieachtergrond, regio’s. StatLine: Jeugdmonitor https://jmopendata.cbs.nl/#/JM/nl/dataset/71009ned/table?dl=21563 (2023).</Citation></Reference><Reference><Citation>Wulf Hanson, S. et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 328, 1604–1615 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId><ArticleId IdType="pmc">9552043</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisi, G. F. et al. Cross-sectional survey on long term sequelae of pediatric COVID-19 among Italian pediatricians. Children (Basel) 8, 769 (2021).</Citation></Reference><Reference><Citation>Osmanov, I. M. et al. Risk factors for long covid in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 59, (2022).</Citation></Reference><Reference><Citation>Borch, L., Holm, M., Knudsen, M., Ellermann-Eriksen, S. &amp; Hagstroem, S. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur. J. Pediatr. 181, 1597–1607 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId><ArticleId IdType="pmc">8742700</ArticleId></ArticleIdList></Reference><Reference><Citation>Erol, N., Alpinar, A., Erol, C., Sari, E. &amp; Alkan, K. Intriguing new faces of Covid-19: persisting clinical symptoms and cardiac effects in children. Cardiol. Young-. 32, 1085–1091 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951121003693</ArticleId><ArticleId IdType="pubmed">34407902</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya, A. A. et al. Long COVID in children and adolescents. World J. Pediatr. 17, 495–499 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId><ArticleId IdType="pmc">8414448</ArticleId></ArticleIdList></Reference><Reference><Citation>Smane, L., Roge, I., Pucuka, Z. &amp; Pavare, J. Clinical features of pediatric post-acute COVID-19: a descriptive retrospective follow-up study. Italian J. Pediatr. 47, 177 https://doi.org/10.1186/s13052-021-01127-z (2021).</Citation></Reference><Reference><Citation>Buonsenso, D. et al. Preliminary evidence on long COVID in children. Acta Paediatr. 110, 2208–2211 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId><ArticleId IdType="pmc">8251440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg, S. et al. Long COVID symptoms in SARS-CoV-2-positive children aged 0-14 years and matched controls in Denmark (LongCOVIDKidsDK): a national, cross-sectional study. Lancet Child Adolesc. Health 6, 614–623 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00154-7</ArticleId><ArticleId IdType="pubmed">35752194</ArticleId><ArticleId IdType="pmc">9221683</ArticleId></ArticleIdList></Reference><Reference><Citation>Heching, H. J. et al. Electrocardiographic changes in non-hospitalised children with COVID-19. Cardiol. Young-. 32, 1910–1916 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951121005138</ArticleId><ArticleId IdType="pubmed">34986922</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson, T., Shafran, R. &amp; Ladhani, S. N. Long COVID in children and adolescents. Curr. Opin. Infect. Dis. 35, 461–467 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000854</ArticleId><ArticleId IdType="pubmed">36098262</ArticleId><ArticleId IdType="pmc">9553244</ArticleId></ArticleIdList></Reference><Reference><Citation>Roge, I. et al. Comparison of Persistent Symptoms After COVID-19 and Other Non-SARS-CoV-2 Infections in Children. Front Pediatr. 9, 752385 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.752385</ArticleId><ArticleId IdType="pubmed">34778143</ArticleId><ArticleId IdType="pmc">8586002</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmermann, P., Pittet, L. F. &amp; Curtis, N. How Common is Long COVID in Children and Adolescents? Pediatr. Infect. Dis. J. 40, e482–e487 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId><ArticleId IdType="pmc">8575095</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn, L. M. et al. Post–COVID-19 Condition in Children. JAMA Pediatr. 177, 1226–1228 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapediatrics.2023.3239</ArticleId><ArticleId IdType="pubmed">37721744</ArticleId><ArticleId IdType="pmc">10507591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bygdell, M., Kindblom, J. M., Martikainen, J., Li, H. &amp; Nyberg, F. Incidence and Characteristics in Children with Post–COVID-19 Condition in Sweden. JAMA Netw. Open 6, e2324246 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.24246</ArticleId><ArticleId IdType="pubmed">37466944</ArticleId><ArticleId IdType="pmc">10357335</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk, A. L. et al. Post–COVID-19 Conditions Among Children 90 Days After SARS-CoV-2 Infection. JAMA Netw. Open 5, e2223253 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.23253</ArticleId><ArticleId IdType="pubmed">35867061</ArticleId><ArticleId IdType="pmc">9308058</ArticleId></ArticleIdList></Reference><Reference><Citation>Brackel, C. L. H. et al. Pediatric long-COVID: An overlooked phenomenon? Pediatr. Pulmonol. 56, 2495–2502 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.25521</ArticleId><ArticleId IdType="pubmed">34102037</ArticleId><ArticleId IdType="pmc">8242715</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Pujol, J. et al. Post COVID-19 Condition in Children and Adolescents: An Emerging Problem. Front Pediatr. 10, 894204 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.894204</ArticleId><ArticleId IdType="pubmed">35633949</ArticleId><ArticleId IdType="pmc">9130634</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni, E. et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc. Health 5, 708–718 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId><ArticleId IdType="pmc">8443448</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso, D. et al. Post-COVID Condition in Adults and Children Living in the Same Household in Italy: A Prospective Cohort Study Using the ISARIC Global Follow-Up Protocol. Front Pediatr. 10, 834875 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.834875</ArticleId><ArticleId IdType="pubmed">35529336</ArticleId><ArticleId IdType="pmc">9070551</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta, M., Gupta, N. &amp; Esang, M. Long COVID in children and adolescents. Prim Care Companion CNS Disord 24, 21r03218 (2022).</Citation></Reference><Reference><Citation>Pellegrino, R., Chiappini, E., Licari, A., Galli, L. &amp; Marseglia, G. L. Prevalence and clinical presentation of long COVID in children: a systematic review. Eur. J. Pediatr. 181, 3995–4009 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-022-04600-x</ArticleId><ArticleId IdType="pubmed">36107254</ArticleId><ArticleId IdType="pmc">9476461</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce, C. A. et al. COVID-19 and children. Science (1979) 377, 1144–1149 (2022).</Citation></Reference><Reference><Citation>Tulling, A. J. et al. Severe Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children From Wild-type to Population Immunity: A Prospective Multicenter Cohort Study With Real-time Reporting. Pediatr. Infect. Dis. J. https://doi.org/10.1097/INF.0000000000004098 (2023).</Citation></Reference><Reference><Citation>National Institute for Public Health and the Environment (RIVM). Varianten van het coronavirus SARS-CoV-2. https://www.rivm.nl/corona/actueel/virusvarianten .</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence, Practitioners, R. C. of G. &amp; Scotland, H. I. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE Guidelines 1–35 (2020).</Citation></Reference><Reference><Citation>Varni, J. W. The PedsQL Measurement Model. https://www.pedsql.org/ (2023).</Citation></Reference><Reference><Citation>van Muilekom, M. M. et al. Psychometric properties of the Patient-Reported Outcomes Measurement Information System (PROMIS®) Pediatric Anger Scale in the Dutch general population. Psychol. Assess. 33, 1261–1266 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/pas0001051</ArticleId><ArticleId IdType="pubmed">34197165</ArticleId></ArticleIdList></Reference><Reference><Citation>Peersmann, S. H. M. et al. Psychometric properties and CAT performance of the PROMIS pediatric sleep disturbance, sleep-related impairment, and fatigue item banks in Dutch children and adolescents. Psychol. Assess. 34, 860–869 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/pas0001150</ArticleId><ArticleId IdType="pubmed">35708925</ArticleId></ArticleIdList></Reference><Reference><Citation>PROMIS. https://www.healthmeasures.net/explore-measurement-systems/promis .</Citation></Reference><Reference><Citation>Klaufus, L. H. et al. Psychometric properties of the Dutch-Flemish PROMIS(®) pediatric item banks Anxiety and Depressive Symptoms in a general population. Qual. Life Res 30, 2683–2695 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02852-y</ArticleId><ArticleId IdType="pubmed">33983618</ArticleId></ArticleIdList></Reference><Reference><Citation>Luijten, M. A. J., van Litsenburg, R. R. L., Terwee, C. B., Grootenhuis, M. A. &amp; Haverman, L. Psychometric properties of the Patient-Reported Outcomes Measurement Information System (PROMIS®) pediatric item bank peer relationships in the Dutch general population. Qual. Life Res 30, 2061–2070 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-021-02781-w</ArticleId><ArticleId IdType="pubmed">33606180</ArticleId><ArticleId IdType="pmc">8233291</ArticleId></ArticleIdList></Reference><Reference><Citation>Morello, R. et al. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study. EClinicalMedicine 59, 101961 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101961</ArticleId><ArticleId IdType="pubmed">37073325</ArticleId><ArticleId IdType="pmc">10101848</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Sante, G. et al. Immunopathology of SARS-CoV-2 infection: a focus on t regulatory and b cell responses in children compared with adults. Children 9, 681 (2022).</Citation></Reference><Reference><Citation>Long COVID Kids. Feedback on the Long Covid Clinics. Preliminary healthcare experiences survey findings. https://www.longcovidkids.org/post/feedback-on-the-long-covid-clinics-preliminary-healthcare-experiences-survey-findings#viewer-dge2d (2023).</Citation></Reference><Reference><Citation>Buonsenso, D. et al. Paediatric long COVID studies should focus on clinical evaluations that examine the impact on daily life not just self-reported symptoms. Acta Paediatr. 113, 778–780 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.17129</ArticleId><ArticleId IdType="pubmed">38287466</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso, D. et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future Microbiol 17, 551–571 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0031</ArticleId><ArticleId IdType="pubmed">35264003</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow, A. K. et al. Postacute/Long COVID in Pediatrics: Development of a Multidisciplinary Rehabilitation Clinic and Preliminary Case Series. Am. J. Phys. Med Rehabil. 100, 1140–1147 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001896</ArticleId><ArticleId IdType="pubmed">34793374</ArticleId><ArticleId IdType="pmc">8594395</ArticleId></ArticleIdList></Reference><Reference><Citation>NvK. NVK Handreiking Post-COVID Syndroom. https://www.nvk.nl/themas/kwaliteit/overige-kennisdocumenten/document?documentregistrationid=170917888 (2022).</Citation></Reference><Reference><Citation>A clinical case definition for post COVID-19 condition in children and adolescents by expert consensus, 16 February 2023. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post-COVID-19-condition-CA-Clinical-case-definition-2023-1 .</Citation></Reference><Reference><Citation>World Health Organization. a Clinical Case Definition for Post Covid-19 Condition in Children and Adolescents By Expert Consensus. 1–99 (2023).</Citation></Reference><Reference><Citation>Baldi, F. et al. Cardiopulmonary Exercise Testing in Children With Long COVID: A Case-controlled Study. Pediatr. Infect. Dis. J. (2024) https://doi.org/10.1097/INF.0000000000004371 .</Citation></Reference><Reference><Citation>Delogu, A. B. et al. Autonomic cardiac function in children and adolescents with long COVID: a case-controlled study. Eur. J. Pediatr. 183, 2375–2382 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-024-05503-9</ArticleId><ArticleId IdType="pubmed">38446228</ArticleId><ArticleId IdType="pmc">11035407</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso, D., Morello, R., De Rose, C., Spera, F. &amp; Baldi, F. Long-term outcome of a child with postcovid condition: Role of cardiopulmonary exercise testing and 24-h Holter ECG to monitor treatment response and recovery. Pediatr. Pulmonol. 58, 2944–2946 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.26578</ArticleId><ArticleId IdType="pubmed">37378466</ArticleId></ArticleIdList></Reference><Reference><Citation>Spera, F. R. et al. Post-COVID Postural Orthostatic Tachycardia Syndrome and Inappropriate Sinus Tachycardia in the Pediatric Population. Curr. Clin. Microbiol Rep. 11, 115–125 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40588-024-00217-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis, H. E., McCorkell, L., Vogel, J. M. &amp; Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 21, 133–146 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId><ArticleId IdType="pmc">9839201</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, E. Y., Morrow, A. K. &amp; Malone, L. A. Exploring the Influence of Pre-Existing Conditions and Infection Factors on Pediatric Long COVID Symptoms and Quality of Life. Am. J. Phys. Med. Rehabil. (2023) https://doi.org/10.1097/PHM.0000000000002363 .</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>